Caffeic Acid Phenethyl Ester Induces Vascular Endothelial Growth Factor Production and Inhibits CXCL10 Production in Human Dental Pulp Cells

• Published in: Current Issues in Molecular Biology Vol. 44; no. 11; pp. 5691 - 5699
• Main Authors: Kuramoto, Hitomi, Nakanishi, Tadashi, Takegawa, Daisuke, Mieda, Katsuhiro, Hosaka, Keiichi
• Format: Journal Article
• Language: English
• Published: MDPI AG 15.11.2022; MDPI
• Subjects: anti-inflammatory effect; caffeic acid phenethyl ester; Cytokines; dental pulp cells; Inflammation; Protein kinases; pulpitis; Vascular endothelial growth factor; vital pulp therapy; Japan
• ISSN: 1467-3045; 1467-3037; 1467-3045
• DOI: 10.3390/cimb44110385

The survival rate of root non-vital teeth is lower than that of vital teeth. Therefore, to preserve the dental pulp is very important. The vascular endothelial growth factor (VEGF) is the most potent angiogenic factor involved in the vitality of dental pulp including reparative dentin formation. Caffeic acid phenethyl ester (CAPE) is a physiologically active substance of propolis and has some bioactivities such as anti-inflammatory effects. However, there are no reports on the effects of CAPE on dental pulp inflammation. In this study, we investigated the effects of CAPE on VEGF and inflammatory cytokine production in human dental pulp cells (HDPCs) to apply CAPE to an ideal dental pulp protective agent. We found that CAPE induced VEGF production from HDPCs. Moreover, CAPE induced the phosphorylation of p38 mitogen-activated protein kinase (MAPK), extracellular signal-regulated kinases (ERK), and stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) in HDPCs. Furthermore, CAPE inhibited C-X-C motif chemokine ligand 10 (CXCL10) production in Pam3CSK4- and tumor necrosis factor-alpha (TNF-α)-stimulated HDPCs. In conclusion, these results suggest that CAPE might be useful as a novel biological material for vital pulp therapy by exerting the effects of VEGF production and anti-inflammatory activities.